Table 3.

Stratification analysis of susceptibility in KD patients.

Variables	rs1751034 (IVIG-R/IVIG-S)		p	OR (95% CI)	pa	Adjusted OR (95% CI)	Adjusted pb	combined analysis (IVIG-R/IVIG-S)		p	OR (95% CI)	pa	Adjusted OR (95% CI)	Adjusted pb
	TT/TC	CC						0–2	3–6
Age, months
≤60	118/545	11/19	0.0172	2.67 (1.24–5.77)	0.0122	2.65 (1.23–5.71)	0.0133	69/384	60/180	0.0020	1.86 (1.26–2.74)	0.0018	1.86 (1.26–2.74)	0.0018
>60	18/45	1/3	0.8764	0.83 (0.08–8.56)	0.8780	0.87 (0.08–8.96)	0.9036	15/25	4/23	0.0375	0.29 (0.08–1.00)	0.0503	0.29 (0.08–1.01)	0.0509
Gender
Male	90/404	7/13	0.0821	2.42 (0.94–6.23)	0.0677	2.35 (0.91–6.08)	0.0775	54/279	43/138	0.0392	1.61 (1.03–2.52)	0.0378	1.62 (1.03–2.55)	0.0354
Female	46/186	5/9	0.1816	2.25 (0.72–7.02)	0.1640	2.32 (0.74–7.31)	0.1517	30/130	21/65	0.2999	1.40 (0.74–2.63)	0.2969	1.47 (0.78–2.78)	0.2373

^aTwo-sided χ² test for distributions between Kawasaki disease patients with IVIG resistance and IVIG sensitivity.

^bAdjusted for age and gender, stratified by gender (adjusted for age), and stratified by age (adjusted for gender).

Bold values indicate value of p less than 0.05.